A detailed history of Bank Of America Corp transactions in Immix Biopharma, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 115 shares of IMMX stock, worth $197. This represents 0.0% of its overall portfolio holdings.

Number of Shares
115
Previous 115 -0.0%
Holding current value
$197
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$1.81 - $3.06 $208 - $351
115 New
115 $0
Q4 2023

Feb 14, 2024

BUY
$2.82 - $7.27 $4,495 - $11,588
1,594 New
1,594 $11,000
Q4 2022

Feb 10, 2023

BUY
$0.75 - $2.43 $7 - $24
10 New
10 $0

Others Institutions Holding IMMX

About Immix Biopharma, Inc.


  • Ticker IMMX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 13,910,100
  • Market Cap $23.9M
  • Description
  • Immix Biopharma, Inc., a clinical-stage biopharmaceutical company, engages in developing various tissue-specific therapeutics in oncology and inflammation in the United States and Australia. The company is developing IMX-110 that is in Phase 1b/2a clinical trials for the treatment of soft tissue sarcoma and solid tumors; IMX-111, a tissue-specif...
More about IMMX
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.